Evidence map›Paper›PMID 42146293›Full record

ArticleCJC open2026

Distal Vessel Diameter and Antegrade Crossing Success in Chronic Total Occlusion Percutaneous Coronary Intervention.

Ning Yin, Ping Wang, Yuan Shan, Qiuyu Li, Xiaolong Lin, Xiaowen Bo, Tian Zhou, Hao Zhang, Siyuan Chen, Hainan Yang and 3 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in CJC open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Ning YinCenter for Coronary Artery Disease (CCAD), Beijing Anzhen Hospital, Capital Medical University, and Beijing Institute of Heart, Lung, and Blood Vessel Diseases, Beijing, China.
Ping WangCenter for Coronary Artery Disease (CCAD), Beijing Anzhen Hospital, Capital Medical University, and Beijing Institute of Heart, Lung, and Blood Vessel Diseases, Beijing, China.
Yuan ShanCivil Aviation General Hospital, Beijing, China.
Qiuyu LiCenter for Coronary Artery Disease (CCAD), Beijing Anzhen Hospital, Capital Medical University, and Beijing Institute of Heart, Lung, and Blood Vessel Diseases, Beijing, China.
Xiaolong LinCenter for Coronary Artery Disease (CCAD), Beijing Anzhen Hospital, Capital Medical University, and Beijing Institute of Heart, Lung, and Blood Vessel Diseases, Beijing, China.
Xiaowen BoCenter for Coronary Artery Disease (CCAD), Beijing Anzhen Hospital, Capital Medical University, and Beijing Institute of Heart, Lung, and Blood Vessel Diseases, Beijing, China.
Tian ZhouCenter for Coronary Artery Disease (CCAD), Beijing Anzhen Hospital, Capital Medical University, and Beijing Institute of Heart, Lung, and Blood Vessel Diseases, Beijing, China.
Hao ZhangCenter for Coronary Artery Disease (CCAD), Beijing Anzhen Hospital, Capital Medical University, and Beijing Institute of Heart, Lung, and Blood Vessel Diseases, Beijing, China.
Siyuan ChenDepartment of Cardiology, National Cardiovascular Disease Regional Center for Anhui, the First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.
Hainan YangCenter for Coronary Artery Disease (CCAD), Beijing Anzhen Hospital, Capital Medical University, and Beijing Institute of Heart, Lung, and Blood Vessel Diseases, Beijing, China.
Shujuan ChengCenter for Coronary Artery Disease (CCAD), Beijing Anzhen Hospital, Capital Medical University, and Beijing Institute of Heart, Lung, and Blood Vessel Diseases, Beijing, China.
Jinghua LiuCenter for Coronary Artery Disease (CCAD), Beijing Anzhen Hospital, Capital Medical University, and Beijing Institute of Heart, Lung, and Blood Vessel Diseases, Beijing, China.
Qian FanCenter for Coronary Artery Disease (CCAD), Beijing Anzhen Hospital, Capital Medical University, and Beijing Institute of Heart, Lung, and Blood Vessel Diseases, Beijing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Chronic total occlusion (CTO) is a particularly challenging subtype of ischemic heart disease, significantly elevating the risk of heart failure and sudden cardiac death. Percutaneous coronary intervention (PCI) is the primary revascularization approach. However, the success rate of antegrade PCI (A-PCI) for CTO remains relatively low. Although the distal vessel diameter is recognized as a critical anatomic parameter in A-PCI, it has received limited attention in studies of related populations. Methods: This retrospective study included 502 CTO patients treated with antegrade PCI from July 2023 to September 2024. The relationship between the distal vessel diameter and the antegrade crossing success rate was investigated using logistic regression analysis and receiver operating characteristic curve analysis. Results: Antegrade crossing success was achieved in 72.5% (364 of 502 patients). The distal vessel diameter was significantly smaller in the failure group (1.60 ± 0.39 mm) compared to the success group (1.94 ± 0.41 mm; Conclusions: Distal vessel diameter is the most powerful independent angiographic predictor of antegrade crossing success in CTO-PCI, with a predictive significance surpassing that of established proximal lesion characteristics such as cap ambiguity.

Indexed as

chronic total occlusiondistal vessel diameterindependent predictorpercutaneous coronary interventionsuccess rate

Identifiers

PMID42146293
PMCPMC13174223

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.